ticker nerd logo
United Therapeutics Corp

United Therapeutics Corp Stock Forecast & Price Prediction

Live United Therapeutics Corp Stock (UTHR) Price
$212.34

5

Ratings

  • Buy 5
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$212.34

P/E Ratio

P/E Ratio not available for UTHR

Volume Traded Today

$254,100

Dividend

Dividends not available for UTHR

52 Week High/low

261.54/204.44

United Therapeutics Corp Market Cap

$0

🛑 Alert: These ten stocks could have higher potential than $UTHR 🛑

Before you buy UTHR you’ll want to see this list of ten stocks that have huge potential. Want to see if UTHR made the cut? Enter your email below

UTHR Summary

From what 5 stock analysts predict, the share price for United Therapeutics Corp (UTHR) might increase by 54.75% in the next year. This is based on a 12-month average estimation for UTHR. Price targets go from $309.00 to $375.00. The majority of stock analysts believe UTHR is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

UTHR Analyst Ratings

About 5 Wall Street analysts have assignedUTHR 5 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect United Therapeutics Corp to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on UTHR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

UTHR stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

julian harrison
BTIG

Hold

None

rated

Nov 1, 2023
carter gould
Barclays

Hold

$94.0

upgraded

May 17, 2019
joseph schwartz
SVB Securities

Hold

$126.0

maintained

Apr 3, 2017
michael yee
Jefferies

Hold

$110.0

reiterated

Feb 23, 2017
david steinberg
Jefferies

Hold

None

reiterated

Jul 12, 2016
adnan butt
Guggenheim

Hold

$150.0

reiterated

Mar 11, 2016
robyn karnauskas
Truist Financial

Hold

$150.0

maintained

Jul 29, 2015
bret holley
Guggenheim

Hold

$105.0

rated

Sep 2, 2014
salveen richter
Goldman Sachs

Hold

$76.0

rated

Oct 29, 2013
jonathan aschoff
Roth Capital

Hold

None

downgraded

Feb 26, 2013

UTHR Company Information

UTHR
United Therapeutics Corp (UTHR)

When did it IPO

1999

Staff Count

0

Country

Sector/Industry

/

CEO

Market Cap

$0

United Therapeutics Corp(UTHR) Financial Data

In 2023, UTHR generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that UTHR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.00%
  • Gross profit TTM $0
  • Return on assets TTM 0.00%
  • Return on equity TTM 0.00%
  • Profit margin %
  • Book value 0.00%
  • Market capitalisation $0
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year N/A
  • EPS next year N/A

United Therapeutics Corp(UTHR) Latest News

... ...

Similar Stocks to United Therapeutics Corp UTHR

🛑 Alert: These ten stocks could have higher potential than $UTHR 🛑

Before you buy UTHR you’ll want to see this list of ten stocks that have huge potential. Want to see if UTHR made the cut? Enter your email below

...

UTHR Frequently asked questions

The highest forecasted price for UTHR is $375.00 from hartaj singh at Oppenheimer.

The lowest forecasted price for UTHR is $309.00 from tiago fauth from Wells Fargo

The UTHR analyst ratings consensus are 5 buy ratings, 0 hold ratings, and 0 sell ratings.